Nick Norwitz breaks down a 2024 trial showing atorvastatin cut GLP-1 levels roughly in half, raised blood sugar, and triggered insulin resistance. Researchers reversed the damage with a bile acid supplement. The study got almost no press coverage.
Did you know the world's most prescribed drug might be fueling demand for the trendiest one? Metabolically speaking? Yeah, statins, taken by 1 in 4 people over 40, lower GLP-1 hormone levels by nearly 50%. This was demonstrated in a landmark 2024 human trial published in Cell Metabolism where researchers found that 20mg of atorvastatin increased average blood sugar, caused insulin resistance, and lowered GLP-1 levels by half in human patients. But here's the kicker. The researchers actually reversed this damage in humans using a simple bile acid supplement. Now, this is not medical advice, this is just information. But what I really want is for you to ask yourself the question: Why didn't this make headlines?
